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Abstract
Background: The expression levels of many genes show wide natural variation among strains or
populations. This study investigated the potential for animal strain-related genotypic differences to
confound gene expression profiles in acute cellular rejection (ACR). Using a rat heart transplant
model and 2 different rat strains (Dark Agouti, and Brown Norway), microarrays were performed
on native hearts, transplanted hearts, and peripheral blood mononuclear cells (PBMC).
Results: In heart tissue, strain alone affected the expression of only 33 probesets while rejection
affected the expression of 1368 probesets (FDR 10% and FC ³ 3). Only 13 genes were affected by
both strain and rejection, which was < 1% (13/1368) of all probesets differentially expressed in
ACR. However, for PBMC, strain alone affected 265 probesets (FDR 10% and FC ³ 3) and the
addition of ACR had little further effect. Pathway analysis of these differentially expressed strain
effect genes connected them with immune response, cell motility and cell death, functional themes
that overlap with those related to ACR. After accounting for animal strain, additional analysis
identified 30 PBMC candidate genes potentially associated with ACR.
Conclusion: In ACR, genetic background has a large impact on the transcriptome of immune cells,
but not heart tissue. Gene expression studies of ACR should avoid study designs that require cross
strain comparisons between leukocytes.
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Background
Acute cellular rejection (ACR) is a major cause of morbid-
ity and mortality among cardiac transplant patients [1-3].
Prompt diagnosis with early intervention by appropriate
adjustment of immunosuppressive medications can
reverse ACR, while delayed treatment of ACR can lead to
graft injury or loss. Conversely, unnecessary escalation of
immunosuppression exposes patients to an increased risk
of infections that can also be life-threatening [4]. Unfortu-
nately, symptoms and signs of ACR are often nonspecific.
Diagnosis relies on serial cardiac biopsies, an invasive and
costly procedure. In addition, ACR in its early stages can
be a patchy process such that histopathologic examina-
tion of heart tissue can both under- and over-diagnose its
presence [5,6]. Noninvasive, sensitive, and specific tests
that reliably detect ACR in its earliest stages would greatly
simplify the management of cardiac transplant patients,
increase graft survival, and improve clinical outcomes.
These issues combined with the advent of high-through-
put functional genomic and proteomic methodologies
have fueled a search for ACR biomarkers, as well as new
therapeutic targets.
To date, clinical studies have not convincingly identified
ACR biomarkers that appear suitable for diagnostic testing
across diverse patient populations [7]. Observational gene
discovery studies have been performed in ACR [8]. How-
ever, proposed panels based on gene expression changes
in blood lack biological plausibility and independent rep-
lication [7]. Background noise from genotypic heteroge-
neity may have hampered these investigations. Proof of
principle experiments using animal models of ACR that
impose uniformity not achievable in clinical studies have
also attempted to find candidate biomarkers. However,
many of these studies have directly compared cells and tis-
sues that originated from different animal strains [9-14].
Underlying genotypic differences have the potential to
confound these experiments and lead to erroneous con-
clusions. Furthermore, this source of error is compounded
and magnified in high-dimension, discovery-driven plat-
forms such as microarrays that measure thousands of end-
points.
Natural variation in gene expression is known to be exten-
sive across human populations [15-18] and animal strains
[19-22]. Depending on the tissue and mouse strains
examined, genotypic background appears to significantly
affect the expression of 1 to 2% of the entire transcriptome
[20-22]. These studies raise legitimate concerns about our
ability to distinguish signal (phenotype of interest) from
noise (heterogeneity or strain effects) in biomarker dis-
covery studies. While genetic background can potentially
influence the results of any study, animal investigations
that require the use of more than one strain are at partic-
ular risk. Strain differences in animals and heterogeneity
across human populations may significantly influence the
transcriptomes of individuals to the extent that pheno-
typic differences of interest such as non-rejecting versus
rejecting may be difficult or impossible to detect.
To date, the impact of strain differences or in essence gen-
otypic heterogeneity on transcriptomic profiling has not
been investigated in animal models of organ transplanta-
tion. Moreover, strain effects have not been quantified in
tissues of interest nor have differences been thematically
analyzed to determine whether study interpretation might
be jeopardized. Here, the potential confounding effects of
animal strain differences on expression profiling was
examined in a heterotopic rat heart transplant model.
RNA from native hearts, transplanted hearts, and periph-
eral blood mononuclear cells (PBMC) from normal and
transplanted animals were interrogated using high-den-
sity oligonucleotide microarrays and analyzed for effects
attributable to animal strain as well as rejection. Under-
standing the impact of genotypic heterogeneity on tran-
scriptomic profiles is likely to improve experimental
designs, increasing scientific accuracy for identifying
promising biomarkers.
Methods
Animal Care
The protocol described in the current study was approved
by the Animal Care and Use Committee (ACUC) of the
Clinical Center of the National Institutes of Health (NIH).
Animal care followed the criteria of the ACUC of the Clin-
ical Center of the NIH.
Histology
All specimens were processed for histopathology using
hematoxylin and eosin staining. Histological changes
were blindly assessed by a pathologist, using the Interna-
tional Society for Heart and Lung Transplantation
(ISHLT) grading system for rejection [23,24].
Heterotopic Cardiac Transplantation
Fourteen cardiac transplantations (9 isogeneic and 5 allo-
geneic) were performed using a modified version of the
heterotopic cardiac transplantation model reported by
Yokoyama et al [25]. Briefly, after heparinization, donor
hearts were procured from Dark Agouti (DA) animals,
flushed with Lactated Ringers, and prepared for transplan-
tation with ligation of pulmonary vessels, creation of an
atrial septal defect and disruption of the tricuspid valve
leaflets via a right atriotomy. In isogeneic transplants, the
recipient animal strain was Dark Agouti (DA to DA), and
in allogeneic transplants the recipient animal strain was
Brown Norway (DA to BN). In this model, the animal
strains have major antigen mismatches and allografts lose
pulsatility on post-transplant day 6 with histologic ISHLT
grade 3R rejection. Heterotopic transplantation was per-
formed by anastomosis of the donor ascending aorta to
the recipient abdominal aorta and the donor right atriumBMC Genomics 2009, 10:280 http://www.biomedcentral.com/1471-2164/10/280
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to the recipient inferior vena cava using microsurgical
techniques. Upon re-establishment of blood flow, all
transplanted hearts resumed spontaneous contractions,
had coordinated atrioventricular activity, and were free of
gross surgical injury at the time of closure.
Specimen Procurement
On post transplant day 6, specimens procured from isoge-
neic transplants (Figure 1A) consisted of DA isograft
hearts (n = 4), DA native hearts (n = 4), and DA PBMC (n
= 9). On post transplant day 6, specimens procured from
allogeneic transplants (Figure 1B) consisted of DA allo-
graft hearts (n = 5), BN native hearts (n = 5), and BN
PBMC (n = 5). Specimens procured from untransplanted
animals (Figure 1C) consisted of DA PBMC (n = 3) and
BN PBMC (n = 3). Cross-sections of both ventricles and
the interventricular septum were preserved in RNAlater
(Ambion Inc., Austin, TX) for oligonucleotide array anal-
ysis and frozen at -70°C until processing.
Microarrays
PBMC were isolated using the Nycoprep density gradient
(Axis-Shield, Oslo, Norway). A cell count and differential
were performed on all samples. Total RNA was prepared
from PBMC using the RNeasy Mini kit with DNase treat-
ment (Qiagen Inc., Valencia, CA). For PBMC, mes-
sageAmp II aRNA kit (Ambion Inc.) was used to process
total RNA to cDNA and cRNA. Total RNA from heart tis-
sue was prepared using RNeasy Mini kits with DNAase
and Proteinase K treatment (Qiagen Inc). For heart tissue,
total RNA (10 mg) was reverse transcribed using the Super-
Script II Custom kit (Invitrogen, Carlsbad, CA). cDNA
cleanup was performed using cDNA Sample Cleanup
modules (Affymetrix, Santa Clara, CA). cDNA (1 mg) was
used as a template for in vitro transcription and biotin
labeling reaction using a BioArray High Yield kit (Enzo
Life Sciences, Farmingdale, NY). cRNA cleanup was per-
formed using cRNA Sample Cleanup modules (Affyme-
trix).
Fragmentation and hybridization was performed accord-
ing to Affymetrix standard methodology. The Affymetrix
RAE230A and RAE230 2.0 microarray chips were used for
heart tissue samples and PBMC respectively. Microarrays
were washed and stained using the standard format for
the Affymetrix Fluidics Station (Affymetrix). The probe
Experimental groups and specimen procurement Figure 1
Experimental groups and specimen procurement. (A) Isogeneic transplants consisted of a strain DA donor heart 
placed into the abdomen of a strain DA recipient rat. Specimens procured from isogeneic transplants consisted of strain DA 
isograft and native heart, and strain DA blood.(B) Allogeneic transplants consisted of a strain DA donor heart placed into the 
abdomen of a strain BN recipient rat. Specimens procured from allogeneic transplants consisted of strain DA allograft and 
strain BN native heart, and strain BN blood. (C) Untransplanted animals were strain DA and BN rats that did not receive an 
isograft or an allograft heart. Specimens procured from untransplanted animals consisted of strain DA and strain BN blood.
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arrays were scanned using the Affymetrix Scanner G-3000.
GeneChip Operating System (GSOS; Affymetrix) was used
to quantify gene expression. Result quality was assessed
by comparison to historical values for this laboratory.
Quantitative PCR
TaqMan® (ABI, Rockville, MD) quantitative real time –
polymerase chain reaction (qRT-PCR) was utilized to
quantify mRNA levels. Sufficient total RNA was available
from the PBMC preparations of 3 isogeneic transplants, 3
allogeneic transplants and 5 untransplanted rats. Gene
specific probes and PCR primers for glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), chemokine (c-c
motif) ligand 9 (Ccl9), integrin alpha L (Itgal), s100 cal-
cium binding protein A9 (S100a9), granzyme B (Gzmb),
pancreatic trypsin 1 (Prss1), and lectin galactose binding
soluble 5 (Lgals5) were purchased from ABI (Foster City,
CA). The High-capacity cDNA Archive kit (ABI, Foster
City, CA) was used to prepare cDNA from 2 mg of total
RNA. Resulting cDNA was used for qRT-PCR in triplicate
according to the standard ABI protocol. The target mRNA
of Ccl9, Itgal, S100a9, Gzmb, Prss1 and Lgals5 were nor-
malized to GAPDH. Relative mRNA amounts were calcu-
lated as previously described [26]. Final results were
expressed as fold change.
Oligonucleotide Microarray Data Analysis
Output from Affymetrix GCOS (Gene Chip Operating
Software, Affymetrix, Inc. Santa Clara, CA) was stored in
the NIHGCOS database. Affymetrix signal intensities were
retrieved and assembled for further statistical analysis
using MSCL Analysts Toolbox [27], a microarray analysis
package that uses custom written scripts for JMP (SAS
Institute, Cary, NC). Signal intensities were normalized to
median values and log transformed. The data discussed in
this publication have been deposited in the National
Center for Biotechnology Information's (NCBI) Gene
Expression Omnibus (GEO) [28] and are accessible
through GEO series accession number GSE6342 [29].
Principal component analysis (PCA), a tool for visualizing
a multivariate response, was performed on the entire gene
chip and is used to illustrate differences between various
groups. The significance of individual principal compo-
nents (PC) was calculated by numerical simulation using
a program written with Matlab (Mathworks, Inc., Natick,
MA). The program calculates a PCA for simulated random
data 1000 times, retaining the percentage of variance
explained by the first PC. If the percentage variance
explained by the first PC of the actual data is larger than
95% of the values obtained for random data, this PC is
considered significantly large at the p £  0.05 level. The sec-
ond PC is tested similarly, by considering the percentage
of remaining variance explained, and comparing it to the
comparable value for random data. The first two principal
components (PC) were visualized in two-dimensional
plots (PC1 vs. PC2).
Differences in heart tissue gene expression and differences
in PBMC gene expression were assessed by ANOVA. A
false discovery rate (FDR) of 10% [30], a present call
(Pcall) of at least 50% in either of the two groups being
compared, and a fold change (FC) of at least 3 was
required to declare a probeset as differentially expressed.
In heart tissue, strain effect was defined in native hearts as
the log-ratio of expression levels of native hearts (BN)
from allogeneic transplants to that of native hearts (DA)
from isogeneic transplants. Rejection effect was defined in
transplanted hearts as the log-ratio of allografts (DA) to
isografts (DA) expression levels. Probesets manifesting
differential expression attributable to strain, rejection, or
both were then identified for heart tissue [Additional file
1]. For example, if all 3 criteria (FDR £  10%, FC ³ 3, Pcall
³ 50% in either group being compared) were met for the
native heart log-ratio, but not for the transplanted heart
log-ratio then the differential expression for that probeset
would be considered attributable to strain. In PBMC, the
strain effect was defined by the log-ratio of expression lev-
els for untransplanted BN rats over untransplanted DA
rats. Due to the requirements of the experimental design
(transplanted hearts were always of strain DA) the rejec-
tion effect in PBMC could not be separately measured
(isogeneic transplants were hosted by DA rats and alloge-
neic transplants were hosted by BN rats). Therefore, in
transplanted animals, the combined strain plus rejection
effects were defined in PBMC as the log-ratio of expression
levels for allograft recipients (BN) over isograft recipients
(DA). Thus, probesets manifesting differential expression
attributable to strain in untransplanted animals, strain
plus rejection in transplanted animals or both were iden-
tified for PBMC [Additional file 2]. For example, in PBMC,
if all 3 criteria (FDR £  10%, FC ³ 3, Pcall ³ 50% in either
group being compared) were met for the untransplanted
log-ratio, but not for the transplanted log-ratio then the
differential expression for that probeset would be consid-
ered attributable to strain.
In PBMC, to arrive at a list of genes which demonstrate a
rejection effect independent of animal strain, we further
analyzed the "strain plus rejection effect" list. PBMC genes
whose "strain plus rejection" effect was 3-fold larger (up
or down) than the strain effect alone and met a post-hoc
unadjusted P £  0.01 criterion were considered to demon-
strate a rejection effect independent of animal strain
(Table 1 and 2). These genes nominally associated with
rejection in rat PBMC were then compared to previously
identified rejection-related genes from studies of human
PBMC after cardiac transplant [8,31,32]. To accomplish
this, rat gene probesets were mapped to Entrez gene iden-
tifiers using standard Affymetrix annotations [33]. These
were then mapped to Homologene identifiers [34] whichBMC Genomics 2009, 10:280 http://www.biomedcentral.com/1471-2164/10/280
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were then mapped to the homologous human gene iden-
tifiers.
Gene lists were analyzed with Ingenuity® Systems Pathway
Analysis (Ingenuity® Systems, Redwood City, California)
[35] and with the Database for Annotation, Visualization
and Integrated Discovery (DAVID; NIAID, NIH) [36].
Comparative analyses for enrichment of canonical path-
ways, Gene Ontology terms and Kyoto Encyclopedia of
Genes and Genomes (KEGG) pathways were performed
between each pair of lists. Each test of enrichment is a
two-sided Fisher's exact test.
Results
Histological Evaluation
Hematoxylin and eosin stains were performed on trans-
planted hearts procured on post-transplant day 6. Allo-
grafts were characterized by diffuse inflammation and
necrosis consistent with ISHLT grade 3 R. Isografts exhib-
ited minimal histological changes consistent with ISHLT
grade 0 R.
A Principal Component Analysis of Microarray Results
A PCA in essence creates metagene projections that define
major patterns in a data set. The first component explains the
largest amount of variability followed in order by the 2nd, 3rd,
and 4th components, etc. Applying a PCA to the microarray
results from native and transplanted hearts provided a visual
representation of the sources of variability in this experi-
ment. PC1 encompassed a significantly large proportion
(42.5%, p < 0.05) of the experimental variability and largely
depicted the effect of cardiac rejection (Figure 2A). Allograft
hearts separate widely from isograft hearts primarily along
the PC1 axis. PC2 encompassed the next largest source of the
Table 1: Candidate genes induced by acute cellular rejection relative to the strain effect in peripheral blood mononuclear cells
Gene Title Gene Symbol Entrez Gene Strain+Rejection 
Effect FC
Strain Effect FC Strain+Rejection /
Strain FC
p-value
ring finger protein 
(C3H2C3 type) 6 
(predicted)
Rnf6_predicted 304271 0.40 0.01 40.54 1.44E-11
membrane-spanning 
4-domains, subfamily A, 
member 7 (predicted)
Ms4a7_predicted 293744 0.91 0.03 31.66 2.07E-03
S100 calcium binding 
protein A9 (calgranulin B)
S100a9 94195 3.55 0.32 11.05 2.63E-03
complement component 1, 
q subcomponent, gamma 
polypeptide
C1qg 362634 4.07 0.46 8.84 7.39E-03
distrobrevin binding 
protein 1
Dtnbp1 641528 0.75 0.10 7.61 1.36E-04
matrix metallopeptidase 14 
(membrane-inserted)
Mmp14 81707 4.22 0.59 7.19 3.83E-03
Thyroid hormone receptor 
associated protein 6 
(predicted)
Thrap6_predicted 299905 0.27 0.04 7.09 1.25E-03
myxovirus (influenza virus) 
resistance 2
Mx2 286918 0.09 0.02 5.88 3.09E-05
prolylcarboxypeptidase 
(angiotensinase C) 
(predicted)
Prcp_predicted 293118 1.02 0.21 4.89 1.53E-04
2',5'-oligoadenylate 
synthetase 1, 40/46 kDa
Oas1 192281 1.33 0.28 4.69 1.33E-06
high mobility group box 1 Hmgb1 25459 0.68 0.17 3.92 1.21E-07
COX15 homolog, 
cytochrome c oxidase 
assembly protein (yeast)
Cox15 309391 0.87 0.23 3.87 1.92E-05
RT1 class II, locus Ba RT1-Ba 309621 0.60 0.17 3.60 3.23E-04
complement factor B Cfb 294257 0.91 0.27 3.40 4.27E-04
interferon induced 
transmembrane protein 3
Ifitm3 361673 0.89 0.27 3.22 1.86E-04
interferon-induced protein 
with tetratricopeptide 
repeats 3
Ifit3 309526 0.35 0.11 3.11 4.13E-03
granzyme B Gzmb 171528 0.64 0.21 3.02 1.87E-04
granzyme A Gzma 266708 0.70 0.23 3.00 4.25E-04
The p-value column is derived from a post hoc test that the Strain+Rejection FC/Strain FC is not equal to 1.BMC Genomics 2009, 10:280 http://www.biomedcentral.com/1471-2164/10/280
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experimental variability (7.9%), predominantly attributable
to surgical effect of transplantation. Isografts separated from
in situ native hearts along PC2. The native heart group con-
sists of hearts from 2 different rat strains (BN and DA) which
were histologically normal whether or not the animal was an
allograft or isograft recipient. Native hearts remained closely
grouped along both PC1 and PC2. This suggests that animal
strain has little or no effect on gene expression in heart tissue.
In contrast to heart tissue, PBMC, which are mostly T-lym-
phocytes, displayed a gene expression pattern dominated
by strain effects that obscured any contribution from car-
diac rejection. An initial analysis comparing animals with
rejection (allograft recipients; BN rats) to those without
rejection (isograft recipients; DA rats) indicated broad dif-
ferences in gene expression and the possibility of multi-
ple, strong biomarkers that could distinguish these
phenotypes (Figure 2B). Allograft and isograft recipients
separated clearly from each other along the PC1 axis.
However, the addition of untransplanted animals to this
analysis revealed that these transcriptomic differences
were almost entirely attributable to rat strain rather than
cardiac rejection. Note that expression profiles from
untransplanted BN and DA rats similarly separate from
each other along the PC1 axis (17% of the experimental
variability; p < 0.05). These untransplanted rats grouped
closely with their respective strain of transplanted rats
whether or not the animals had ACR (Figure 2B). PC2 was
not significant and did not further resolve these groups.
Strain Effects on the Expression Profiles of Heart Tissue 
and PBMC in ACR
Next, differentially expressed probesets between experi-
mental groups were identified using standardized selec-
tion criteria (see Methods) to assess the relative impact of
rat strain and ACR at the transcript level. In heart tissue,
the number of strain-related differentially expressed
probesets (33; BN vs. DA native hearts) was small com-
pared to the much larger number of differentially
expressed rejection-related probesets (1368; DA allograft
vs. DA isograft). Furthermore, of the 33 strain-related
probesets in heart tissue, only 13 (representing 13
uniquely named genes) were also associated with rejec-
tion; a very small fraction (<1%) of all rejection-related
differentially expressed probesets in heart tissue (Figure
3A) [Additional file 1]. In contrast, for PBMC the number
of differentially expressed probesets was very similar
among untransplanted (265; BN vs. DA) and transplanted
animals (279; BN strain, allograft recipient vs. DA strain,
isograft recipient). Importantly, of the 265 strain-related
differentially expressed probesets in untransplanted ani-
mals, 120 (45%) also met criteria for differential expres-
sion in transplanted animals (Figure 3B) [Additional file
2], a substantial overlap. Two inflammatory response
genes (Ccl9, Itgal) were selected from the PBMC overlap
category for qRT-PCR. Ccl9 expression was much higher
while Itgal was lower in BN compared to DA animals, irre-
spective of transplant status, across both platforms (Figure
4A – B).
Table 2: Candidate genes suppressed by acute cellular rejection relative to the strain effect in peripheral blood mononuclear cells
Gene Title Gene Symbol Entrez Gene Strain+Rejection 
Effect FC
Strain Effect FC Strain+Rejection /
Strain FC
p-value
similar to Glycophorin LOC688972 688972 0.55 10.07 0.05 8.26E-04
pancreatic trypsin 1 Prss1 24691 0.08 0.91 0.09 3.49E-04
similar to RIKEN cDNA 
1110063G11 (predicted)
RGD1311960_predi
cted
305095 0.09 0.97 0.10 1.09E-04
transcription factor Dp 2 
(predicted)
Tcfdp2_predicted 300947 0.22 1.94 0.11 2.53E-03
Translocase of inner 
mitochondrial membrane 
9 homolog (yeast)
Timm9 171139 2.20 17.91 0.12 1.19E-03
lectin, galactose binding, 
soluble 5
Lgals5 25475 0.18 1.36 0.13 5.55E-04
immunoglobulin heavy 
chain 1a (serum IgG2a)
Igh-1a 299352 0.46 3.21 0.14 2.19E-03
selenium binding protein 
2
Selenbp1 140927 0.20 1.24 0.16 7.24E-03
SNF1-like kinase Snf1lk 59329 3.31 18.46 0.18 7.67E-03
pre-eosinophil-associated 
ribonuclease-2
LOC474169 474169 1.15 4.82 0.24 5.67E-05
2,3-bisphosphoglycerate 
mutase
Bpgm 296973 0.27 1.04 0.26 9.24E-03
unc-5 homolog C 
(C. elegans)
Unc5c 362049 1.11 3.42 0.32 1.01E-03
The p-value column is derived from a post hoc test that the Strain+Rejection FC/Strain FC is not equal to 1.BMC Genomics 2009, 10:280 http://www.biomedcentral.com/1471-2164/10/280
Page 7 of 16
(page number not for citation purposes)
Principal component (PC) analysis Figure 2
Principal component (PC) analysis. (A) Depicts variability in gene expression of native hearts from allograft (BN) and iso-
graft recipients (DA), and of transplanted hearts from allograft (DA) and isograft recipients (DA). Principal component 1 (PC1) 
on the x-axis, and PC2 on the y-axis, accounted for 42.5% (p < 0.05), and 7.9% of total variability in gene expression, respec-
tively. The samples visually separate into 3 main groups based on their immunological status: (1) rejecting transplanted hearts 
from allograft recipient (DA allograft); (2) non-rejecting transplanted hearts from isograft recipient (DA isograft); (3) and native 
hearts (DA and BN). (B) Depicts variability in gene expression of peripheral blood mononuclear cells (PBMC) from trans-
planted and untransplanted animals. Transplanted and untransplanted animal samples were processed in two batches, and the 
results as shown were batch-corrected for this nuisance factor. PC1 (x-axis) and PC2 (y-axis) accounted for 17% (p < 0.05) and 
8% of the total variability in gene expression, respectively. Samples visually separate into 2 main groups: (1) PBMC from 
untransplanted DA animals and isograft recipients (DA); and (2) PBMC from untransplanted BN animals and allograft recipients 
(BN). The separation of animals primarily into two groups based on strain, and not ACR, indicates that most of the gene 
expression variability in PBMC during rejection was due to strain.
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To better visualize the extent of discordance or concord-
ance in expression profiles within each tissue, bivariate
plots and heat maps were generated using the union of all
probesets differentially expressed in heart tissue or the
union of all probesets differentially expressed in PBMC
(Figure 5). This figure is color coded to track the various
probeset groups as defined by the Venn diagrams shown
in Figure 3. Strain and rejection effects in heart tissue were
found to be highly discordant at the level of individual
probesets (Figure 5A, scatter plot; r = 0.26), again indicat-
ing that any confounding effects of strain in heart tissue
are likely to be small. As clearly seen in the adjacent heat
map (Figure 5A), most probesets had very different
expression patterns comparing the strain effect to the
rejection effect.
In contrast to heart tissue, comparison at the probeset
level of strain effect to the strain plus rejection effect in
PBMC showed a high concordance (Figure 5B, scatter
plot; r = 0.84). Both overlapping and non-overlapping
probesets (Figure 3B), display very comparable expression
patterns (Figure 5B, heat map). These results demonstrate
that rat strain has a large effect on the transcriptomic pro-
file of leukocytes and has the potential to overwhelm the
more subtle signature of ACR. Next, the heart tissue and
PBMC probeset lists were used to perform an unsuper-
vised cluster analysis of their respective microarrays (Fig-
ure 6). For heart tissue (Figure 6A), rejecting hearts
(allografts) formed a distinct group as did nonrejecting
hearts (isografts and native hearts). The latter then further
divided into isografts and native hearts, followed by the
sorting of native hearts into those from BN rats and DA
rats (allogeneic and isogeneic transplants, respectively). In
contrast, PBMC microarrays primarily divided by strain
effect (Figure 6B).
Strain Effects on Pathways and Networks Potentially 
Relevant to ACR Pathogenesis
Thematic analysis is routinely applied to link microarray
results with pathways, networks, and various biological
functions. This approach is considered robust in that
Venn diagram representation of the union of probeset lists Figure 3
Venn diagram representation of the union of 
probeset lists. (A) Depicts the union of the probeset list 
for strain effect (native hearts) and the probeset list for 
rejection effect (transplanted hearts) in heart tissue. Of the 
13 overlapping probesets (13 unique genes), the direction of 
gene expression change was concordant for 11. (B) Depicts 
the union of the probeset list for strain effect (untransplanted 
animals) and the probeset list for strain + rejection effect 
(transplanted animals) in PBMC. Of 120 overlapping 
probesets, the direction of gene expression change was con-
cordant for 119. Figures 5 and 7 are color coded as defined 
by these Venn diagrams.
Strain Effect
Strain Effect Strain + Rejection Effect
Rejection Effect
A. Heart
B. PBMC
Validation of microarray results for genes similarly affected  by strain irrespective of acute cardiac rejection Figure 4
Validation of microarray results for genes similarly 
affected by strain irrespective of acute cardiac rejec-
tion. Two inflammatory response genes, Ccl9 and Itgal, were 
selected from the peripheral blood mononuclear cell (PBMC) 
overlap category shown in Figure 3B. Microarray and qRT-
PCR results are from the same animals. (A) Strain effect in 
PBMC shown as the fold change in gene expression compar-
ing untransplanted BN and DA rats. (B) Strain plus rejection 
effects in PBMC shown as the fold change in gene expression 
comparing allogeneic transplant recipients (BN) and isoge-
neic transplant recipients (DA). Ccl9 expression was higher 
and Itgal was lower in BN compared to DA animals irrespec-
tive of transplant status across both platforms.
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Bivariate plots and heat maps of differentially expressed probesets Figure 5
Bivariate plots and heat maps of differentially expressed probesets. (A) Relative gene expression in native (strain 
effect) and transplanted hearts (rejection effect) are plotted on the x and y-axes, respectively in a base 10 log scale. Each circle 
represents one probeset. Probesets are colored to depict group membership as defined by the Venn diagram shown in Figure 
3A. Strain and rejection effects are not highly correlated (R = 0.26). Differences in gene expression due to rejection are mini-
mally confounded by differences in gene expression due to strain in heart tissue. In the heat map, red indicates over-expression 
and green indicates under-expression. From the heat map, it is visually evident that strain and rejection have dissimilar gene 
expression patterns. (B) Relative gene expression in the PBMC of untransplanted (strain effect) and transplanted (strain + 
rejection effect) animals are plotted on the x and y-axes, respectively, in a base 10 log scale. Each circle represents one 
probeset. Probesets are colored to depict group membership as defined by the Venn diagram shown in Figure 3B. Strain effects 
in both the absence and presence of rejection are highly correlated (R = 0.84). Differences in gene expression during rejection 
are unapparent compared to the large background differences attributable to animal strain. In the heat map, red indicates over-
expression and green indicates under-expression. From the heat map it is visually evident that strain in the absence or pres-
ence of rejection is the predominant gene expression pattern. For both (A) and (B), certain probesets appear near each other 
but are placed in different categories as indicated by color coding. The categorization of probesets was based on the contribu-
tion of additional variables not apparent in these scatter plots (see Methods).
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Hierarchical clustering of the union of the probeset lists Figure 6
Hierarchical clustering of the union of the probeset lists. Two-way hierarchical clustering of samples and differentially 
expressed probesets within (A) heart tissue from native and transplanted hearts from isogeneic (i) and allogeneic (a) trans-
plants; and (B) peripheral blood mononuclear cells (PBMC) from untransplanted animals and isogeneic and allogeneic trans-
plants. Rows represent microarray chips and columns represent probesets. Red indicates over-expression and green indicates 
under-expression. The dendrogram illustrates how the samples segregate into groups. For heart tissue, samples segregate 
mainly based on the presence and absence of rejection. For PBMC, samples segregate mainly based on strain irrespective of 
rejection or transplant status.
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Thematic analysis of differentially expressed genes Figure 7
Thematic analysis of differentially expressed genes. (A) Pathway analysis in heart tissue of differentially expressed 
genes associated with strain effect, or rejection effect or overlap region. (B) Pathway analysis of differentially expressed genes 
in peripheral blood mononuclear cells (PBMC) associated with strain alone or strain plus rejection or both (overlap region). 
Genes tested are grouped and color coded as defined by the Venn diagrams shown in Figure 3. For each graph, the threshold 
for significance is 1.3 representing – log 0.05 (unadjusted p = 0.05). In heart tissue, the over-represented functional categories 
such as immune response and cell death were more strongly associated with rejection than with the strain effect. Conversely 
in PBMC, strain effect was strongly linked to pathways indicative of immune response and cell death both in the presence and 
absence of rejection. Results based on an Ingenuity® Systems Pathway Analysis (see Methods).
A. Heart
I
m
m
u
n
e
 
R
e
s
p
o
n
s
e
C
e
l
l
-
T
o
-
C
e
l
l
 
S
i
g
n
a
l
i
n
g
a
n
d
 
I
n
t
e
r
a
c
t
i
o
n
I
n
f
l
a
m
m
a
t
o
r
y
 
D
i
s
e
a
s
e
C
e
l
l
 
D
e
a
t
h
T
i
s
s
u
e
 
M
o
r
p
h
o
l
o
g
y
-
l
o
g
1
0
(
p
-
v
a
l
u
e
)
0
5
10
15
20
Strain Effect
Overlap
Rejection Effect
B. PBMC
I
m
m
u
n
e
 
R
e
s
p
o
n
s
e
C
e
l
l
-
T
o
-
C
e
l
l
 
S
i
g
n
a
l
i
n
g
a
n
d
 
I
n
t
e
r
a
c
t
i
o
n
I
n
f
l
a
m
m
a
t
o
r
y
 
D
i
s
e
a
s
e
C
e
l
l
 
D
e
a
t
h
C
e
l
l
u
l
a
r
 
M
o
v
e
m
e
n
t
I
m
m
u
n
e
 
a
n
d
 
L
y
m
p
h
a
t
i
c
 
S
y
s
t
e
m
D
e
v
e
l
o
p
m
e
n
t
 
a
n
d
 
F
u
n
c
t
i
o
n
-
l
o
g
1
0
(
p
-
v
a
l
u
e
)
0
1
2
3
4
5
6
7
Strain Effect
Overlap
Strain + Rejection EffectBMC Genomics 2009, 10:280 http://www.biomedcentral.com/1471-2164/10/280
Page 12 of 16
(page number not for citation purposes)
results are relatively resistant to arbitrary changes in the
methods and rules used to generate lists of differentially
expressed genes [37]. As such, thematic analyses often
play a large role in determining the final interpretation of
expression profiles. Therefore, strain effects were exam-
ined using Ingenuity® Systems Pathway Analysis (Ingenu-
ity®  Systems, Redwood City, California) [35] for the
presence of thematic signatures that might be miscon-
strued as the consequences of ACR. The rejection effect in
heart tissue was strongly associated with many expected
themes including immune response, cell death, and tissue
morphology (Figure 7A). In contrast, the strain effect in
heart tissue was only weakly associated with these gene
signatures (unadjusted significance threshold p < 0.05).
For PBMC, however, strain effects alone produced very
significant "hits" in several biologically plausible ACR
pathways including immune response, cell death, and cel-
lular movement. Importantly, the magnitudes of the
strain-only effects on these pathways were similar to those
seen in animals with rejection (Figure 7B). Likewise,
another analysis using DAVID (NIAID, NIH) [36] also
strongly associated the strain effect with immune defense,
a thematic signature consistent with ACR.
Genes Associated with ACR in PBMC
Even though the strain effect was larger than the ACR
effect in PBMC, attempting to account for the strain effect
identified 30 candidate genes potentially associated with
ACR. Of these 30 candidates, 18 were induced (Table 1)
and 12 were suppressed (Table 2) in rejection relative to
the strain alone effect. Four of these genes, two induced
(S100a9, Gzmb) and two suppressed (Prss1, Lgals5) by
rejection were selected for qRT-PCR. The qRT-PCR and
microarray fold change ratios (Strain + Rejection Effect/
Strain Effect) for these 4 genes were all directionally con-
cordant (Figure 8).
A thematic analysis (Figure 9) of these 30 genes (Ingenu-
ity®  Systems, Redwood City, California) [35] connect
them to organismal injury, cell death, immune response,
the complement system, and interferon signaling, path-
ways previously associated with allograft rejection. Simi-
larly, a high stringency analysis using DAVID (NIAID,
NIH) [36] also found these genes to be strongly associated
with the immune response and complement activation.
Of the 30 candidate genes, 22 could be mapped to homol-
ogous human genes. These 22 homologues were com-
pared against a list of 97 uniquely named genes compiled
from 3 human studies investigating differential PBMC
gene expression in cardiac ACR [8,31,32]. Two genes, cal-
granulin B (S100a9; S100 calcium binding protein A9)
and granzyme B (Gzmb) were present on both lists. In rats
with ACR, S100a9 was induced 11 fold and Gzmb was
induced 3 fold relative to the strain alone effect.
Discussion
Relatively large expression differences were detected in
PBMC between two strains of rats commonly used in
models of organ transplantation. Conversely, only a small
number of differentially expressed genes in heart tissue
were related to rat strain. The larger effect of strain on gene
expression in PBMC compared to heart tissue may in part
reflect the abundance of strain-specific, self-recognition
molecules that are expressed by lymphocytes. As such,
strain specifically affected genes involved with the
immune response, cell motility, and cell death, functional
categories that might be misconstrued as ACR-related.
Moreover, the magnitude of the strain effect in PBMC (FC
³ 3 for 265 probesets) substantially obscured the gene
expression signature of rejection. Potential markers spe-
cific to ACR could only be identified after measuring and
accounting for the strain effect. Similar variability attribut-
able to genotypic heterogeneity has also been docu-
mented in human populations [16,17,38] and therefore
has major implications for experimental design and
power calculations in patient biomarker studies.
Approximately 85 to 95% of human genetic variation is
attributable to individual heterogeneity within a popula-
tion while the remaining 5 to 15% can be ascribed to dif-
ferences between populations [16,18]. In addition to
Validation of microarray results for genes showing a rejec- tion effect independent of animal strain Figure 8
Validation of microarray results for genes showing a 
rejection effect independent of animal strain. Two 
genes, S100a9 and Gzmb, induced by rejection (Table 1), and 
2 genes, Prss1 and Lgals5, suppressed by rejection (Table 2) 
in peripheral blood mononuclear cells (PBMC) were selected 
for qRT-PCR. Microarray and qRT-PCR are from the same 
animals. The rejection effect in PBMC was defined as the 
strain plus rejection effect divided by the strain effect. Rejec-
tion effects on these 4 genes as measured by microarray and 
qRT-PCR were concordant.
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external influences and epigenetic factors, this back-
ground genetic variation contributes to differences in gene
expression [15-17] that may add unwanted noise to
results from high – throughput methodologies such as
microarrays. Genotypic effects in human PBMC were
found to significantly alter the expression of more than
300 transcripts [38]. Major histocompatibility complex-
associated and interferon-regulated genes were among
those most affected by genotype in human PBMC prepa-
rations. Investigations performed in inbred animals
reduce this source of variability and thereby serve as a
"best case" scenario or "proof of principle." However,
genetic background may still negatively impact the results
and interpretation of animal experiments, a well recog-
nized concern in gene targeting studies [39]. At particular
risk are investigations that require hybrid animals or mul-
tiple animal strains.
Natural variation in gene expression has been well docu-
mented among laboratory strains of fruit flies [19] and
mice [20-22,40]. Expression profiling of brain [20,21],
spleen [21], and liver [22] have determined that 1 to 3%
of mouse transcripts are significantly affected by animal
strain. In addition to these baseline effects, the gene
expression response to seizure was shown to be signifi-
cantly different comparing the brains of two inbred strains
Thematic analysis of candidate genes associated with rejection in peripheral blood mononuclear cells (PBMC) Figure 9
Thematic analysis of candidate genes associated with rejection in peripheral blood mononuclear cells (PBMC). 
Pathway analysis of genes differentially expressed in PBMC in response to acute cardiac rejection (Table 1 and 2) after 
accounting for strain effects. Red indicates over-expression and green indicates under-expression. Results based on an Ingenu-
ity® Systems Pathway Analysis.
Gene Symbol Entrez Gene ID
Cardiovascular Disease (p=0.004)
Organismal Injury (p=0.0004) 
Cell
Death (p=0.0005)
Immune Response (p=0.00006)
Complement System (p=0.05)
Interferon Signaling (p=0.00001)
S100a9 94195
C1qg 362634
Mmp14 81707
Mx2 286918
Prcp_predicted 293118
Oas1 192281
Hmgb1 25459
RT1-Ba 309621
Cfb 294257
Ifitm3 361673
Ifit3 309526
Gzmb 171528
Gzma 266708
Unc5c 362049
LOC474169 474169
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of mice [20]. Even more relevant to immunity and trans-
plant medicine, bone marrow derived macrophages from
5 mouse strains displayed unique transcriptional pheno-
types in response to lipopolysaccharide challenges [40].
Allogeneic animal transplant models typically employ
two immunologically distinct strains to serve as donor
and recipient. Therefore background genotypic effects on
transcript abundance have a real potential to confound
the search for biomarkers and new therapeutic targets. In
the current study, the impact of rat strain on PBMC gene
expression was unexpectedly large and primarily affected
transcripts associated with the immune response, effects
that could be misinterpreted as ACR-related. These results
underscore the importance of experimental designs and
analytical approaches in expression profiling studies that
control for strain effects in animal models and genotypic
heterogeneity in patient populations.
Measuring and then adjusting post hoc for large strain
effects on gene expression identified 30 genes with the
potential to be differentially regulated during rejection in
circulating PBMC. A thematic analysis of this list sug-
gested biological plausibility. However, homologues of
only two of these genes, S100 calcium binding protein A9
and granzyme B have been previously linked to cardiac
rejection in humans [8,32]. Two S100 like binding pro-
teins, myeloid related protein 8 (MRP8) and MRP14, have
been shown to be increased in the serum of patients rela-
tively early in acute renal allograft rejection [41].
Granzyme B has also been found to be over-expressed in
the peripheral blood of patients with acute renal allograft
rejection [42]. Another potentially rejection-related gene
from the current study, high mobility group box 1
(Hmgb1) has been investigated in a previous animal
study of acute rejection [43]. In a murine cardiac trans-
plant model, Hmgb1 expression was significantly
increased in allogeneic compared to isogeneic transplants.
Increased expression of Hmgb1 in allografts was associ-
ated with active secretion of Hmgb1 by infiltrating
immune cells. Blockade of extracellular Hmgb1 signifi-
cantly delayed acute allograft rejection [43].
This study has several limitations. PBMC from trans-
planted animals differed by both transplant type (isoge-
neic vs. allogeneic) and animal strain. If strain and ACR
interacted in a non-additive manner then the selection of
rejection-related genes might have been unreliable. These
genes require confirmation using an experimental design
that avoids the need for cross strain comparisons. Like-
wise, it would be prudent to validate any results in more
than one rat strain. Robust genes that identify rejection
within multiple rat strains might be more likely to serve as
reliable biomarkers in patients with their inherent hetero-
geneity. Another potential limitation of our analysis was
the assumption that systemic effects of ACR on native
hearts were minimal and that expression differences in
native hearts were almost entirely due to strain. Nonethe-
less, the heart tissue strain effect, examined only in native
hearts, was relatively small. Finally, in our study and oth-
ers, some gene expression differences attributed to ACR in
heart tissue may reflect the detection of strain-associated
gene expression attributable to recipient lymphocytes that
have infiltrated the donor allograft.
Despite these limitations, our results have implications
for recent efforts to identify biomarkers of ACR in periph-
eral blood [8,31,32,44-46]. Human genetic variation has
a substantial impact on gene expression independent of
exogenous factors and conditions [15-17,38]. Notably,
the influence of genetic variation on transcript abundance
appears to be particularly strong in cells of the immune
system [17,38]. Baseline genetic differences between
human transplant recipients may make it difficult to iden-
tify a universally applicable set of biomarkers for nonin-
vasively detecting acute cellular rejection. Complex
interactions between genetic background (polymor-
phisms), comorbidities, and immunosuppressive regi-
mens may further degrade the performance characteristics
of biomarkers in this heterogeneous patient population.
Conclusion
Tissue specific differences in strain between donor and
recipient animals can confound gene expression profiles
in animal models of ACR. In heart tissue, there is a very
modest strain effect which shares little in common with
the effects of rejection in transplanted hearts. In PBMC,
there is a substantial strain effect in untransplanted ani-
mals which shares a great deal in common with the com-
bined effects of strain and rejection in transplanted
animals. When performing animal gene expression stud-
ies, animal strain effects should be considered and
accounted for in the design and analysis of the study.
Given the magnitude of strain-related effects in PBMC
preparations, the most prudent approach would be to
avoid cross-strain comparisons in leukocyte studies of
transplant rejection. These findings may also have impli-
cations for gene expression studies in diverse, genetically
heterogeneous patient populations undergoing transplan-
tation.
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